Cargando…
Cancer targeted drug delivery using active low-density lipoprotein nanoparticles encapsulated pyrimidines heterocyclic anticancer agents as microtubule inhibitors
Recently, nanomedicine had the potential to increase the delivery of active compounds to specific cell sites. Nano-LDL particles are recognized as an excellent active nano-platform for cancer-targeted delivery. Loading of therapeutic agents into nano-LDL particles achieved by surface loading, core l...
Autores principales: | Jaragh-Alhadad, Laila, Behbehani, Haider, Karnik, Sadashiva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427048/ https://www.ncbi.nlm.nih.gov/pubmed/36029014 http://dx.doi.org/10.1080/10717544.2022.2117435 |
Ejemplares similares
-
Low-density lipoprotein encapsulated thiosemicarbazone metal complexes is active targeting vehicle for breast, lung, and prostate cancers
por: Jaragh-Alhadad, Laila, et al.
Publicado: (2022) -
Design and encapsulation of anticancer dual HSP27 and HER2 inhibitor into low density lipoprotein to target ovarian cancer cells
por: Alhadad, Laila J., et al.
Publicado: (2020) -
Methoxybenzamide derivative of nimesulide from anti-fever to anti-cancer: Chemical characterization and cytotoxicity
por: Jaragh-Alhadad, Laila A., et al.
Publicado: (2022) -
Polymer encapsulation of anticancer silver–N-heterocyclic carbene complexes
por: Mohamed, H. A., et al.
Publicado: (2018) -
In silico drug discovery of SIRT2 inhibitors from natural source as anticancer agents
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2023)